MYGN vs TOST · rev $824.5M vs P/E 161, rev $3.54B
Myriad Genetics Inc (MYGN) versus Toast Inc (TOST) — a side-by-side from cached financials, not a winner call.
Myriad Genetics Inc (MYGN) is a diagnostics & research company listed on NASDAQ.
Toast Inc (TOST) is a software - infrastructure company listed on US.
Latest reported MYGN revenue for 2025-12-31 was $824.5M. Net income was -$365.9M. Revenue was down 1.6% from 2024-12-31 to 2025-12-31. MYGN currently screens at market cap $413.7M.
Latest reported TOST revenue for 2026-06-30 was $3.54B. Net income was $280.0M. TOST currently screens at market cap $25.21B and trailing P/E 161.4.
MYGN currently screens at market cap $413.7M. TOST currently screens at market cap $25.21B and trailing P/E 161.4.
Not investment advice. Open the MYGN and TOST stock pages for the full models.
Not investment advice.